#pharmaceuticals

The Kenyan government has stopped parallel importation of medicines and health technologies to enhance oversight and protect citizens from substandard and counterfeit medical products. Health Cabinet Secretary Aden Duale announced that all pharmaceutical imports must now go through approved channels to ensure compliance with quality, safety, and efficacy standards.

The Nigeria Customs Service (NCS) has revealed an attempt to smuggle unregistered pharmaceutical products into Nigeria using a counterfeit registration number from the National Agency for Food and Drug Administration and Control (NAFDAC). Comptroller-General of Customs, Bashir Adeniyi, announced the seizure of N53 billion worth of drugs and expired pharmaceuticals, which were handed over to the National Drug Law Enforcement Agency (NDLEA) and NAFDAC.

Shareholders of Neimeth International Pharmaceuticals Plc have approved the Board of Directors' plans to raise additional capital aimed at accelerating the company's expansion and completing its pharmaceutical manufacturing facility in Amawbia, Anambra State. This decision was made during the company's 67th Annual General Meeting (AGM), which was held virtually, where shareholders unanimously approved all resolutions proposed by the board.

Kenya's efforts to boost local drug manufacturing are facing challenges due to fiscal and tax unpredictability. Frequent policy shifts and inconsistent incentives are creating uncertainty for investors, which undermines long-term planning for pharmaceutical manufacturers aiming to expand their operations.